Forma Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Forma Therapeutics Holdings (Nasdaq: FMTX) is a clinical-stage biopharmaceutical company committed to addressing rare hematologic diseases and cancers. The company will participate in three notable investor conferences: the SVB Leerink 10th Annual Global Healthcare Conference on February 24, the H.C. Wainwright Global Life Sciences Conference on March 9, and the Oppenheimer 31st Annual Healthcare Conference on March 17. Each presentation will be webstreamed on Forma's website, ensuring stakeholders can access real-time updates and insights on their therapeutic advancements.

Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced that company management will participate in three upcoming investor conferences:

• The SVB Leerink 10^th Annual Global Healthcare Conference taking place Feb. 22-26. Forma will present on Wednesday, Feb. 24 at 1:40 p.m. Eastern Standard Time (EST).
• The H.C. Wainwright Global Life Sciences Conference taking place March 9-10. Forma will present on Tuesday, March 9 at 7:00 a.m. EST.
• The Oppenheimer 31^st Annual Healthcare Conference taking place March 16-17. Forma will present on Wednesday, March 17 at 8:40 a.m. EST.

Webcasts of the conference presentations will be available in the “News & Investors” section of Forma’s website at www.formatherapeutics.com.

About Forma Therapeutics

Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Our R&D engine combines deep biology insight, chemistry expertise and clinical development capabilities to create drug candidates with differentiated mechanisms of action focused on indications with high unmet need. Our work has generated a broad proprietary portfolio of programs with the potential to provide profound patient benefit. For more information, please visit www.FormaTherapeutics.com or follow us on Twitter @FORMAInc and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210217005230/en/

FAQ

When is Forma Therapeutics participating in the SVB Leerink Global Healthcare Conference?

Forma Therapeutics will present at the SVB Leerink 10th Annual Global Healthcare Conference on February 24 at 1:40 p.m. EST.

What date will Forma Therapeutics present at the H.C. Wainwright Conference?

Forma Therapeutics is set to present at the H.C. Wainwright Global Life Sciences Conference on March 9 at 7:00 a.m. EST.

When is the Oppenheimer Healthcare Conference?

The Oppenheimer 31st Annual Healthcare Conference will take place on March 16-17, with Forma's presentation scheduled for March 17 at 8:40 a.m. EST.

Where can I watch Forma Therapeutics' conference presentations?

Webcasts of Forma Therapeutics' conference presentations will be available in the 'News & Investors' section of their website.

What is the main focus of Forma Therapeutics?

Forma Therapeutics focuses on developing novel therapeutics for rare hematologic diseases and cancers.